These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 20038295

  • 1. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.
    Jakubík J, Randáková A, El-Fakahany EE, Dolezal V.
    BMC Pharmacol; 2009 Dec 28; 9():15. PubMed ID: 20038295
    [Abstract] [Full Text] [Related]

  • 2. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
    Lazareno S, Birdsall B, Fukazawa T, Gharagozloo P, Hashimoto T, Kuwano H, Popham A, Sugimoto M, Birdsall NJ.
    Life Sci; 1999 Dec 28; 64(6-7):519-26. PubMed ID: 10069518
    [Abstract] [Full Text] [Related]

  • 3. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
    Jooste E, Klafter F, Hirshman CA, Emala CW.
    Anesthesiology; 2003 Apr 28; 98(4):906-11. PubMed ID: 12657852
    [Abstract] [Full Text] [Related]

  • 4. Rapacuronium augments acetylcholine-induced bronchoconstriction via positive allosteric interactions at the M3 muscarinic receptor.
    Jooste EH, Sharma A, Zhang Y, Emala CW.
    Anesthesiology; 2005 Dec 28; 103(6):1195-203. PubMed ID: 16306732
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
    Leach K, Loiacono RE, Felder CC, McKinzie DL, Mogg A, Shaw DB, Sexton PM, Christopoulos A.
    Neuropsychopharmacology; 2010 Mar 28; 35(4):855-69. PubMed ID: 19940843
    [Abstract] [Full Text] [Related]

  • 6. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S, Dolezal V, Popham A, Birdsall NJ.
    Mol Pharmacol; 2004 Jan 28; 65(1):257-66. PubMed ID: 14722259
    [Abstract] [Full Text] [Related]

  • 7. Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.
    Jakubík J, Janíčková H, El-Fakahany EE, Doležal V.
    Br J Pharmacol; 2011 Mar 28; 162(5):1029-44. PubMed ID: 20958290
    [Abstract] [Full Text] [Related]

  • 8. Rapacuronium preferentially antagonizes the function of M2 versus M3 muscarinic receptors in guinea pig airway smooth muscle.
    Jooste E, Zhang Y, Emala CW.
    Anesthesiology; 2005 Jan 28; 102(1):117-24. PubMed ID: 15618795
    [Abstract] [Full Text] [Related]

  • 9. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC, Challiss RA, Nahorski SR.
    Br J Pharmacol; 2001 Feb 28; 132(4):950-8. PubMed ID: 11181437
    [Abstract] [Full Text] [Related]

  • 10. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J, Bacáková L, El-Fakahany EE, Tucek S.
    Mol Pharmacol; 1997 Jul 28; 52(1):172-9. PubMed ID: 9224827
    [Abstract] [Full Text] [Related]

  • 11. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J, Bacáková L, el-Fakahany EE, Tucek S.
    J Pharmacol Exp Ther; 1995 Sep 28; 274(3):1077-83. PubMed ID: 7562472
    [Abstract] [Full Text] [Related]

  • 12. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
    Tränkle C, Kostenis E, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug 28; 364(2):172-8. PubMed ID: 11534857
    [Abstract] [Full Text] [Related]

  • 13. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov 28; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 14. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
    Lazareno S, Birdsall NJ.
    Mol Pharmacol; 1995 Aug 28; 48(2):362-78. PubMed ID: 7651370
    [Abstract] [Full Text] [Related]

  • 15. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, Sugimoto M.
    Mol Pharmacol; 1999 Apr 28; 55(4):778-86. PubMed ID: 10101037
    [Abstract] [Full Text] [Related]

  • 16. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT, Avlani VA, Langmead CJ, Herdon HJ, Wood MD, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2007 Aug 28; 72(2):463-76. PubMed ID: 17525129
    [Abstract] [Full Text] [Related]

  • 17. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct 28; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 18. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM, Forde SC, Appadu BL, Lambert DG.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):37-40. PubMed ID: 17588565
    [Abstract] [Full Text] [Related]

  • 19. Weak toxin WTX from Naja kaouthia cobra venom interacts with both nicotinic and muscarinic acetylcholine receptors.
    Mordvintsev DY, Polyak YL, Rodionov DI, Jakubik J, Dolezal V, Karlsson E, Tsetlin VI, Utkin YN.
    FEBS J; 2009 Sep 13; 276(18):5065-75. PubMed ID: 19682302
    [Abstract] [Full Text] [Related]

  • 20. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.
    J Pharmacol Exp Ther; 1999 Jan 13; 288(1):164-70. PubMed ID: 9862767
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.